Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 26, 2025 09:51 ET | Source: Research and Markets

Atrial Fibrillation (AF) Market Trends Analysis Report 2025-2033: Focus on Pharmacological Treatment, Non-pharmacological Treatment, Hospitals, Specialty Clinics

Dublin, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The "Atrial Fibrillation Market Size, Share & Trends Analysis Report by Treatment Type (Pharmacological Treatment, Non-pharmacological Treatment), by...
September 24, 2025 07:30 ET | Source: Cytokinetics, Incorporated

Cytokinetics Announces Call for Proposals for Its Eighth Annual Communications Grant Program

Program to Provide Support of Communications and Outreach for Patient Advocacy Organizations Focused on Cardiovascular Diseases Deadline for Applications is November 3rd, 2025 SOUTH SAN FRANCISCO,...
September 22, 2025 06:20 ET | Source: CELLPROTHERA

CellProthera annonce la publication de ses résultats de phase I/IIb sur la sécurité et la faisabilité des ProtheraCytes® chez des patients souffrant d'insuffisance cardiaque sévère après un infarctus du myocarde.

La publication du JACC-Heart Failure souligne la haute qualité de l'expansion cellulaire, la bonne tolérance, le risque procédural gérable et les signes précoces encourageants d'effets fonctionnels. ...
September 22, 2025 06:20 ET | Source: CELLPROTHERA

CellProthera announces peer-reviewed publication of its Phase I/IIb results on safety and feasibility of ProtheraCytes® in patients with severe heart failure post-myocardial Infarction

JACC-Heart Failure publication highlights high-quality cell expansion, good tolerability, manageable procedural risk and encouraging early signals of functional effects. Mulhouse, France – [DATE] –...
September 16, 2025 03:05 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag AnaCardio har slutfört rekryteringen i sin fas 2a-studie med läkemedelskandidaten AC01

STOCKHOLM, SVERIGE 16 september 2025 Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget AnaCardio har slutfört patientrekryteringen i fas 2a-delen av den kliniska...
September 16, 2025 03:05 ET | Source: Karolinska Development AB (publ)

Karolinska Development’s portfolio company AnaCardio completes patient recruitment in phase 2a study of its drug candidate AC01

STOCKHOLM, SWEDEN September 16, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has completed enrollment in the phase 2a part of its...
August 18, 2025 01:15 ET | Source: Novartis Pharma AG

New Novartis ESC data highlights strength of cardiovascular portfolio

Two VictORION studies will highlight Leqvio’s impact on patient quality of life, and as a cholesterol lowering monotherapyLp(a)FRONTIERS APHERESIS study will assess effect of pelacarsen on reducing...
July 18, 2025 07:40 ET | Source: Research and Markets

Cardiac Amyloidosis Market Research Report 2025-2035 | Advancements in Targeted Therapies and Improved Access Fuel Steady Growth

Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The "Cardiac Amyloidosis Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035" report has been...
June 18, 2025 07:17 ET | Source: Gradient Denervation Technologies

Gradient Denervation Technologies annonce son admission au programme consultatif de la FDA sur le cycle de vie complet des produits pour le développement de son système de dénervation de l’artère pulmonaire

PARIS, 18 juin 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies annonce ce jour son admission au programme pilote TAP (Total Product Life Cycle Advisory Program, programme consultatif sur...
June 18, 2025 07:17 ET | Source: Gradient Denervation Technologies

Gradient Denervation Technologies Announces Acceptance into FDA’s Total Product Life Cycle Advisory Program for Development of its Pulmonary Artery Denervation System

PARIS, June 18, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today that it has been accepted into the Total Product Life Cycle Advisory Program (TAP) Pilot from the U.S. Food...